Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $485 Price Target
Portfolio Pulse from richadhand@benzinga.com
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly (NYSE:LLY) and maintained a $485 price target.
June 20, 2023 | 12:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly and maintained a $485 price target.
The news of Cantor Fitzgerald reiterating an Overweight rating on Eli Lilly and maintaining a $485 price target is positive for the stock. This shows that the analyst has confidence in the company's performance and growth potential. As a result, this news is likely to have a positive short-term impact on Eli Lilly's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100